Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review

Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review

Abstract Background Evidence remains contradictory regarding second-line therapy in patients with Kawasaki disease (KD) refractory to initial intravenous immunoglobulin (IVIg). The objective of this study aims to evaluate the efficacy and safety of three treatments [i.e. a second IVIg infusion, meth...

Full description

Bibliographic Details
Main Authors: Courtney B. Crayne, Chace Mitchell, Timothy Beukelman
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Pediatric Rheumatology Online Journal
Subjects:
IVIg-refractory Kawasaki disease
Infliximab
Coronary artery aneurysm
Online Access:http://link.springer.com/article/10.1186/s12969-019-0380-z

Internet

http://link.springer.com/article/10.1186/s12969-019-0380-z

Similar Items